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1. Introduction
Obsessive–compulsive disorder (OCD) is a mental disorder characterized by absurd, recurrent
and uncontrollable thoughts (obsessions) that produce anxiety, which are followed by
repetitive behaviors (compulsions) aimed at reducing anxiety. OCD may be looked upon as a
condition in which the affected person frequently experiences irresistible urges to perform
repetitive rituals (compulsions). OCD may be defined as the irruption in the mind of uncon‐
trollable, egodystonic and recurrent thoughts, impulses or images. In OCD, repetitive rituals
serve to counteract the anxiety precipitated by obsessions. The OCD patients realize the
irrational nature of thoughts and rituals but feel helpless and hopeless about controlling them.
Obsessive-Compulsive disorder can impair all areas of brain functioning and produce
devastating effects on patients and their families. Classic psychoanalysis, as pioneered by
Freud, interpreted obsessive-compulsive disorder as unconscious conflicts, which were
defensive and punitive (Rapoport et al., 1993). In modern psychoanalysis, obsessive-compul‐
sive disorder is described as a portrayal of ambivalence, with confusion of thoughts and actions
that are paradoxically manifested by rigidity and abnormal behaviors. Dynamic psychiatry
interprets obsessive-compulsive symptoms as a reflection of feelings and thoughts that
provoke aggressive or sexual actions that might produce shame, weakness, or loss of pride
(Baer, 1993). The thoughts and behaviors associated with OCD are viewed as senseless, and
egodystonic and they stand contradictory to the individual’s motives, goals, identity, and self-
perception thereby creating significant subjective distress. The excessive nature of the com‐
pulsion, however, creates its own distress and it appears that the individual may be caught up
in a kind of negative reinforcement loop (David et al., 2004) The obsessive-compulsive
spectrum disorders are Tourette’s disorder, Body dysmorphic disorder, Hypochondriasis,
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Pathological jealousy, Trichotillomania, Skin picking, Nail biting, Compulsive buying,
Kleptomania, Pathological gambling, Nonparaphilic sexual disorders, Obsessive compulsive
personality disorder.
OCD is a psychiatric affliction with a lifetime prevalence of 1–3% (Rasmussen and Eisen, 1992;
Sasson et al., 1997). According to the Diagnostic and Statistical Manual of Mental Disorders
(4th ed; DSM IV), the essential features of OCD are recurrent obsessions and/or compulsions
(e.g., doubting, checking, washing) that are time consuming (i.e., they take more than 1 h a
day) or cause marked distress or significant impairment. To date, the most effective treatments
for OCD are pharmacological treatment, using serotonin reuptake inhibitors (SRIs, e.g.,
Masand and Gupta, 1999; Piccinelli et al., 1995; Pigott and Seay, 1999; Stein et al., 1995; Zohar
et al., 1992), and behavioral treatment, using the response exposure and prevention technique
(e.g., Simpson et al., 2004). Yet, around 30% of the patients are refractory to pharmaco- and
behavioral therapy (Eddy et al., 2004). Some of these treatment-resistant patients are treated
by lesions to structures and pathways within basal gangliathalamo- cortical circuits (Lopes et
al., 2004) as well as by high frequency stimulation (HFS) of the ventral striatum region
(Aouizerate et al., 2004, 2005; Greenberg et al., 2006, 2008; Rauch et al., 2006; Sturm et al., 2003)
the subthalamic nucleus (Mallet et al., 2008), and the thalamic reticular nucleus and the inferior
thalamic peduncles (Jimenez et al., 2007; Jimenez-Ponce et al., 2009). Several neural systems
have been implicated in the pathophysiology of OCD: The results of neuroimaging studies in
OCD patients have implicated most consistently the orbitofrontal cortex, the cingulated cortex
and the basal ganglia, and more recently also regions within the parietal lobe, in the patho‐
physiology of obsessions and compulsions (for review see Menzies et al., 2008; Rotge et al.,
2009; Saxena et al., 1998; Stein, 2000). Dysregulation of the serotonergic (5-HT) system has been
suggested primarily on the basis of the effectiveness of SRI’s and selective serotonin reuptake
inhibitors (SSRI’s) in alleviating obsessions and compulsions in patients (Zohar and Insel,
1987; Zohar et al., 1992), and has received further support from neurobiological, pharmaco‐
logical and more recently genetic data (for review see Murphy et al., 2001; Ozaki et al., 2003;
Sasson and Zohar, 1996; Stein, 2000, but see Baumgarten and Grozdanovic, 1998). Abnormal‐
ities of the dopaminergic system have also been implicated in the pathophysiology of OCD,
based on surplus therapeutic benefits obtained with co-administration of SSRI’s and dopamine
blockers (McDougle et al., 1990, 1994; Sasson andZohar, 1996) as well as on clinical observa‐
tions of obsessions and compulsions in basal ganglia-related disorders, such as Tourette’s
syndrome (Frankel et al., 1986; Grad et al., 1987; Pitman et al., 1987). More recently, an
increasing body of evidence points also to the involvement of the glutamatergic system in OCD
(for review, see Pittenger et al., 2006), including association of certain polymorphisms in the
NMDA receptor gene with susceptibility to OCD N. Albelda, D. Joel / Neuroscience and
Biobehavioral Reviews 36 (2012) 47–63 49 (Arnold et al., 2004); elevated glutamate levels in the
cerebro-spinal fluid of drug-naïve patients (Chakrabarty et al., 2005); correlations between
symptom severity and the level of several glutamatergic metabolites (Starck et al., 2008);
improvement of symptoms following treatment with d-cycloserine (DCS), a partial NMDA
agonist (blinded controlled trials, Kushner et al., 2007; Wilhelm et al., 2008), riluzole, a
glutamatergic antagonist (open-label trials, Coric et al., 2005; Grant et al., 2007), and meman‐
tine, a non-competitive NMDA antagonist (an open-label trial, Aboujaoude et al., 2009). There
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is also some evidence suggesting the involvement of nitric oxide (NO) in OCD. Atmaca et al.
(2005) found that OCD patients have higher NO levels in their plasma compared to healthy
subjects and that these levels are positively correlated with the severity of OC symptoms. The
possibility that high NO levels are related to OC symptoms is supported by the fact that SSRI’s,
anti-dopaminergic drugs and the NMDA antagonist memantine, all used to treat OCD
patients, inhibit the synthesis of NO (Almeida et al., 2006; Park and West, 2009; Zhang et al.,
2010). Reports that life events related to the female hormonal cycle may trigger or exacerbate
OCD in women patients (Abramowitz et al., 2003; Labad et al., 2005; Maina et al., 1999) suggest
that ovarian hormones play a modulatory role in OCD (Uguz et al., 2007). Indeed, gonado‐
tropine-releasing hormone (GnRH) agonists were reported to ameliorate OC symptoms in
OCD patients (Casas et al., 1986; Eriksson, 2000). The understanding and treatment of diseases
such as OCD must rely heavily on appropriate animal models that closely mimic their
behavioral and if possible their neural manifestations. This is especially true for OCD as its
neuropathological mechanisms are still largely unknown, and many patients are either
treatment-resistant or experience only partial alleviation of symptoms. Before reviewing
animal models of OCD that are currently in use, we discuss the criteria for the validation and
evaluation of animal models.
2. Clinical features
The OCD is clinically manifested by a wide range of symptoms. The most common types of
obsessions are related to contamination, pathological doubts, somatic dysfunctions, need for
symmetry, aggression and hyper sexual drive. The classical forms of compulsions include
checking, washing, counting, need to ask, precision and hoarding. In OCD, senseless, repetitive
rituals (such as counting, washing etc.) serve to counteract the anxiety precipitated by
obsessive thoughts e.g. Symmetry and exactness preoccupations. Fears of contamination and
illness produce washing and cleaning compulsions (Leckman et al., 1997). Some symptoms
get stable over a time period i.e. sexual/religious obsessions. The symptoms that is more likely
to change are aggressive and contamination obsessions. Changes usually occur within rather
than between individual symptom dimensions (Mataix-Cols et al., 2002). Patients with OCD
may report only one or, more typically, multiple symptoms that cut across dimensions (Stein
et al., 1997).
Many children with obsessive-compulsive disorder (OCD) suffer from an almost pathological
doubting, which can vary from a mild form to an incapacitating form of extreme severity, in
which the child is uncertain about its own understandings. Other high frequency symptoms
are checking, fear of harming others, obsessions relating to death or sex produce compulsions
serving to avoid a horrible event. Indecisiveness is frequently found in children with OCD and
ranges from difficulty in making minor decisions. Following Group A Beta–Hemolytic
Streptococcal (GABHS) infections, it was noted that OCD symptoms along with choreic
movements in sydenham chorea became worse, and this was mediated by antineuronal
antibodies that adversely affected basal ganglia cells. It was later hypothesized that this
abnormal reaction to GABHS might play a part in the etiology of OCD.1 This subgroup of OCD
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patients has been termed PANDAS (for Pediatric Autoimmune Neuropsychiatric disorders
Associated with Streptococcal Infection). Asbahr, Ramos, Negrao and Gentil presented four
cases of children with PANDAS. They suggested that OCD may occur after repeated strepto‐
coccal infection as all four cases developed OCD only after the second infection. MRI tests
showed that children with PANDAS have enlarged basal ganglia. The frontal-lobe function
compared in 21 children and adolescents with OCD who were approximately 12 years of age
and in matched healthy subjects, investigators found no cognitive impairment on the basis of
performance on frontal tests and concluded that OCD symptoms may not interfere with
cognitive abilities at early stages in the illness. The study with 42 children and adolescents
(mean age, 14 years) and 35 normal subjects and concluded that subjects with OCD have
impaired executive functions and nonverbal memory. Andres administered a neuropsycho‐
logical battery to 35 OCD patients without psychiatric comorbidity aged between 7 and 18
years and 35 healthy controls and found that children and adolescents with OCD had impair‐
ments in visual memory, visual organization.2
The performances of 21 obsessive-compulsive children compared with 21 healthy controls on
neuropsychological tests, including the Stroop test, Wisconsin Card Sorting Test, Verbal
Fluency test, California Verbal Learning Test, Grooved Pegboard Test suggested there were
no differences in neuropsychological performance between obsessive-compulsive children
and the healthy controls. Therefore, it was concluded that obsessive-compulsive children do
not show clinically significant cognitive impairment during the early stages of the illness, but
a deficiency may become significant over time. The doubting and checking are found fre‐
quently in OCD patients which associated with memory dysfunction of OCD patients. The
children with tic disorder frequently show OCD symptoms. The negative emotions such as
anxiety have an adverse effect on memory function. The most striking feature of the symptoms
presented by obsessive-compulsive children is the severity of the psychopathology in the
absence of formal thought disorder. Thus, Obsessive-Compulsive disorder can impair all areas
of brain functioning and produce devastating effects on patients and their families. Therefore,
there is necessity to aware about the OCD in children and different treatments for it’s man‐
agement.
Sr. Obsessions Compulsions
1. Concern with cleanliness (dirts, germs,contamination)
Excessive and ritualized bathing, washing and
cleaning
2. Concern with exactness (symmetry and order) Ritualized arranging and rearranging
3. Concern with household tools (dishes, spoons, soap)
Checking, rechecking and keeping inventory
with detailed description of tools, objects, and
appliances
4. Concern about body secretions (saliva, urine, stool) Rituals to remove body secretions
5. Sexual obsessions (aggressive sexual actions) Ritualized and rigid sexual relationship
Table 1. List of typical obsessive thoughts compelling repetitive actions
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3. Causes
• Serotonin is involved in regulating anxiety
• Abnormality in the neurotransmitter serotonin
• In order to send chemical messages serotonin must bind to the receptor sites located on the
neighboring nerve cells
• OCD suffers may have blocked or damaged receptor sites preventing serotonin from
functioning to full potential
• Possible genetic mutation
• Some people suffering have mutation in the human serotonin transporter gene
Figure 1. OCD patients have lower serotonin levels than control subjects.
4. Epidemiology
The frequency of compulsions in 8-year-old German children, to be 4.6% (moderate severity)
and 2.8% (severe symptomatology). Later, the prevalence of compulsive checking in the same
population (13 years old) was 3.4%, all of moderate severity. 2.3% reported compulsion for
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cleanliness and 4.0% experienced obsessive thoughts. OCD in the child psychiatric population
found as 0.2-1.2%. In an epidemiological study of 5000 high-school students, Flament found
that 0.35% fulfilled the criteria of OCD, as defined by DSM-III (American Psychiatric Associ‐
ation, 1980). They calculated a lifetime prevalence of 0.4%. In their Isle of Wight-study, 2000
children examined at the age of 11 and found no children who fulfilled the criteria for OCD.
They found eight children whom they diagnosed with "mixed emotional disorder" (with
obsessive-compulsive features).
5. Genetics and family lifestyle
Family lifestyle could be regarded as a possible precipitating factor, for developing obsessive-
compulsive symptoms in predisposed children. Family functioning was described in 20
Danish children with OCD and later assessed adaptability and cohesion of the family. In
studies of children and adolescents most surveys show that OCD patients are generally from
white, middle- or upper-class, intact families. Certain myths have prevailed regarding families
with OCD children. The families are often said to show a cultural behaviour that emphasises
cleanliness and perfection. 9% of mothers and 25% of fathers to OCD children had OCD
themselves. 19% of 21 OCD children had one parent with OCD and as many as 52% had parents
with obsessive-compulsive symptoms, without meeting the criteria for OCD, when parents
were interviewed with standard clinical psychiatric assessments. 52% of children with OCD
have a positive family history of OCD amongst first-degree relatives and that risk to relatives
is related to the age of onset of the OCD proband: the younger the onset of OCD in proband,
the higher risk of OCD or Tourette's syndrome in relatives. 24% of referred OCD children had
a first degree relative with OCD.
6. Biological aspects
An electrophysiological investigation in obsessional states informed the presence of altered
neural inhibition in connection with obsessive symptoms. The EEGs of a group of OCD patients
compared with a control group of patients with other neurotic disorders, indicated abnormal
findings in two thirds of the OCD patients, which was not significantly higher than in the
control group. An orbitofrontal-subcortical hyperactivity in children and adolescent OCD
patients may be the result of abnormal neuroanatomical development of these structures. A
report suggested OCD develop by head injuries in four cases. The OCD patients have a
particularly higher range of neurological diseases in childhood.
7. Neurological soft-signs and neuropsychological findings
Soft-signs are non-localized deviant performances in a motor or sensory test, without other
signs or presence of focal neurological disorder. Soft-signs in child psychiatric patients have
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been well studied and implications of soft-signs have been thouroughly analysed in a general
population of pre-school and school-children. 44 out of 54 childhood OCD patients, at the age
from 6 to 20 years, had neurological abnormalities. Of these 44 patients 18 had choreiform
movements, 13 had non-specific neurodevelopmental signs only, eight had left hemisyn‐
drome, and five had miscellaneous abnormalities. Most studies conducted on OCD children
have resulted an overweigth of soft-signs, compared to normal control-groups. The children
with early OCD onset, have more soft-signs than children with a later onset. The neurological
soft-signs found in 18.6% of 61 OCD-children and adolescents compared to 14.4% in a control
group consisting of non-psychotic and non-retarded children and adolescents with psychiatric
disorders other than OCD. In studies of children, a pattern of association between OCD and
selected neurological disorders has been long recognized. A prominently left frontal dysfunc‐
tion in OCD patients indicated that cerebral cause had responsible for the obsessive-compul‐
sive symptoms.
8. Pathophysiology
The brain regions impaired in OCD includes dorsolateral prefrontal cortex (DLPC), anterior
cingulate cortex (ACC), basal ganglia, orbito-frontal cortex (OFC), striatum, amygdala,
thalamus and brainstem.
8.1. Dorsolateral prefrontal cortex (DLPC)
It is the most important cortex part for cognitive functions in human beings. The involvement
of the DLPC in working memory was initially demonstrated in primate studies. The DLPC
also plays a role in adaptation to changes in the environment. DLPC plays a crucial role in
focusing attention on specific stimuli and in decision-making (Miller, 1999). Lesions of DLPC
disturb the subject’s ability to process temporal information and impair the successful
performance of goal-directed behaviors. Functional neuroimaging data have shown dimin‐
ished activity in the DLPC of patients suffering with psychiatric disorders such as major
depression and OCD, which may account for the difficulty in overcoming compulsive
behaviors (Saxena et al., 1998).
8.2. Anterior cingulate cortex (ACC)
Neuroimaging studies indicated that the ACC is involved in a variety of cognitive processes
such as attention, motivation, reward, error detection, working memory, problem solving and
action–plan (Bush et al., 2000). There are two major regions within ACC viz. a dorsal region,
known as the cognitive region, and a ventral or affective region. The cognitive region is a part
of attentional netwok and is closely connected with the DLPC, premotor, and parietal cortices
whereas, the affective region is linked to the amygdala, nucleus accumbens, hypothalamus,
anterior insula, hippocampus and OFC and sends projections to the neuro-vegetative, viscero-
motor and endocrine systems. Excessive activation of ACC has been reported in patients
presenting psychiatric disturbances such as phobias, OCD and mood disorders. Moreover,
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electrophysiological studies in man have demonstrated its particular role in error detection
processes.
8.3. Basal ganglia-thalamo-cortical circuits
Basically, the role of the basal ganglia is to integrate the various inputs arriving from the cortex
and to use this information for selecting certain motor and/or cognitive programs. The point
of entry of information to the basal ganglia is through striatum, which receives converging
information from the limbic and associative cortices. It then sends projections to the output
structures, i.e. the globus pallidus pars internalis (Gpi) and the substantia nigra pars reticulata
(SNr), through two pathways: one direct and the other indirect. The indirect pathway succes‐
sively involves the globus pallidus pars externalis (Gpe) and the subthalamic nucleus (STN).
In addition, the cortex sends direct inputs to the STN and the connections between the Gpe
and Gpi.These two pathways seem to play opposite roles in controlling cortical activity.
Activation of the direct loop facilitates the triggering of programs at the cortical level through
a double inhibition. On the other hand, the indirect loop blocks the activation of thalamic relay
by increasing the activity of the Gpi, a GABA-ergic inhibitory structure. Dopamine of nigral
origin seems to facilitate the direct pathway through D1 receptors and plays an inhibitory role
on the indirect pathway through D2 receptors. The pathological activation of segregated closed
loop circuits involving cortex-basal ganglia–thalamus–cortex pathways would produce
reverberating activity and result in a persistent discharge of the innate programs characteristic
of OCD. The clinical manifestations of neuronal disorders of the basal ganglia can be viewed
as a disruption of information processing at the cortical level due to the loss of the focusing
action of subcortical inputs.
8.4. Orbito-frontal cortex (OFC)
The OFC is a large brain region, which encompasses both rostral and ventromedial areas.
Because, it receives multimodal inputs from the temporal association cortex, amygdala and
hypothalamus as well as limbic components of the basal ganglia, it has been viewed as the
highest integration center for emotional processing (Krawezyk, 2002). By analogy with the
Dorsolateral prefrontal cortex (DLPC), which is the prefrontal area for parietal lobe, the OFC
can be regarded as the prefrontal area for the temporal lobe. The OFC seems to play a role in
situations involving incentives/bonus/rewards and in conditions, where the subject has to
make rapid alterations in behavior to accommodate the environmental changes. Several lines
of evidence suggested that OFC played a crucial role in the decision-making process based on
rewards. Patients with orbitofrontal damage experience great difficulties in decision-making.
They also tend to take risks, whether profitable or not (Miller, 1985). Experimental lesions of
OFC in monkeys have shown impairment in reward–related learning tasks and irrespective
of the nature of the sensory context. These monkeys also exhibited an absence of emotional
reaction to environmental stimuli. OFC neurons become particularly active, when the animal
is placed in a situation where, it expects and receives a reward. Interestingly, face selective
neurons have been reported in OFC, which may be relevant in the detection of facial expression
which is a critical point in social decision. These neurons may be involved in the association
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between a positive reward value and a particular facial expression. The OFC seems to play a
predominant role in motivational aspects of decision-making. Among the more posterior
cortical areas, the left inferior parietal cortex and parieto-occipital junction are involved in
cognitive tasks related to visual imagery. The underactivity of these regions could probably
explain the spatial memory deficits and visual memory deficits observed in OCD patients. The
repetitive rituals (compulsions) and aggressive behavior, which is predominant in OCD
patients is probably due to serotonin depletion.
8.5. Striatum
The striatum is known to be formed by two types of information-processing modules: the
striasomes and the matrisomes. The striasomes receive information from the limbic structures
such as amygdala, OFC & ACC (Eblen and Graybiel, 1995). In turn, they send projections to
the dopaminergic neurons of the substantia nigra. These anatomical findings suggest that the
striasomes could also play a role in the emotional modulation of cortical information. The
matrisomes receive information from the lateral parts of the premotor and prefrontal cortices,
which are involved in the anticipation behavior and planning (Flaherty and Graybiel, 1994).
The cholinergic inter-neurons of the striatum, viz. tonically active neurons (TANS), may be
playing a particular role in integrating the information flowing through the striasomes and
matrisomes. These neurons could constitute a neural system that is involved in the processing
of several aspects of information, such as the detection of unpredicted events or the context of
stimulus discrimination (Ravel et al., 2001).
The limbic part of the striatum (ventral striatum) under the control of the dopaminergic
afferents might be involved in reward–driven learning processes. On the other hand, the dorsal
striatum seems to be involved in the procedural learning of behavioral routines that are
performed almost without conscious effort. In particular, in the context of procedural learning,
the disruption of the “readiness” and “release” functions ascribed to the striatum might
support some aspects of OCD pathophysiology. However, the striatum could also play a part
in other processes potentially disrupted in OCD, such as emotional modulation of information
and representation of the expected consequences of action. On the other hand, the performance
of repetitive behaviors in OCD patients might have a positive effect on the reduction of anxiety,
a process that can be assimilated to some form of reward.
8.6. Amygdala
In the past decade, much research has been focused on the neural substrates that are involved
in the expressions of fear and anxiety. The amygdala and its various outputs might play a
major role in mediating the clinical signs and symptoms of fear and anxiety (Le Doux, 2000).
Schematically, the amygdala is comprised of several nuclei, such as the lateral nucleus,
basolateral nucleus and central nucleus. However, recent evidence supports the fundamental
idea that the amygdala is not only involved in negative emotions such as fear and anxiety but
also in reward and motivational processes through reciprocal connections to the nucleus
accumbens and the OFC. Thus, the amygdala appears to play an important role in the
expressions of emotion and motivation, probably through its connections with the OFC, ACC
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and ventral striatum. A dysfunction of this structure, as suggested by some neuroimaging
studies in OCD patients, might mediate the non-specific anxiety experienced relative to
obsessive thoughts.
8.7. Thalamus
The diencephalic position of the thalamus in the brain explains why it receives large cortical
inputs. It participates in emotional expression through the AN (anterior nucleus of the
thalamus), which is connected to the MB (mammillary bodies) and, in turn, sends projections
to the ACC. The putative role of the VA (ventral anterior nucleus of the thalamus) in cognitive
functions involving attention and working memory is based on the link with DLPC. Discrete
parts of the MD (medial dorsal nucleus of the thalamus) seem to be important in both emotional
and cognitive processing through their preferential anatomical connections with the OFC and
DLPC. Thalamic dysfunction has been associated with deficits in executive functions like
planning, goal directed behavior, attention, and working memory (Lacerda et al., 2003).
8.8. Brainstem inputs
The mesocorticolimbic dopaminergic system emanates from the ventral mesencephalon,
which encompasses the Ventral tegmental area (VTA), and projects to the nucleus accumbens
with other limbic ventral striatal regions and cortical areas, especially the OFC, DLPC, ACC.
The effects of the lesions, receptor blocking agents, electrical stimulation and self-administra‐
tion of drugs of abuse suggest the effective contribution of the mesocorticolimbic system in
the attentional, emotional and motivational processes. Dopamine contributes to the organiza‐
tion and regulation of goal-directed behavior. The serotonin-producing neurons are mainly
located in the brainstem raphe nuclei. The description of the anatomy and development of the
brainstem raphe nuclei has shown that they form the largest and most complex neurochemical
efferent system in the human brain. General theories have attributed a broad range of behav‐
ioral functions to serotonin, which is considered as a general inhibitor of motor behavior. In
contrast, reduced serotonin function has been shown to increase exploration, locomotor
activity, aggression and sexual behaviors in animals and human beings (Lucki, 1998). The
repetitive rituals (compulsions) and aggressive behavior, which is predominant in OCD
patients is probably due to serotonin depletion.
• PET Scans show people with OCD have different brain activity from others
• Another theory: miscommunication between the orbital frontal cortex, the caudate nucleus
and the thalamus
• Caudate nucleus doesn’t function properly and causes thalamus to become hyperactive and
sends never-ending worry signals between OFC and thalamus OFC responds by increasing
anxiety
The Group A Beta–Hemolytic Streptococcal (GABHS) infections produce anti-neuronal
antibodies that adversely affect basal ganglia cells, which might lead to the development of
OCD (Swedo et al., 1998). The susceptibility marker that may predispose some individuals to
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develop OCD has been well identified. D8/17 ((the antigen present on the surface of peripheral
blood mononuclear cells) positive individuals develop OCD as a consequence of their
autoimmune response to Group A beta-hemolytic streptococcal infection, a response that is
believed to yield antibodies which cross react with basal–ganglia antigens and produce tissue
damage. The orbitofrontal cortex that had been demonstrated to be overactive in OCD is a
region mediating the active expression of emotional response to significant biological stimuli
as well as the inhibition of behavioral response.
9. Treatment of OCD
9.1. Pharmacological treatments
The serotonin reuptake inhibitors (SRIs) are consistently effective in patients of Obsessive-
compulsive  disorder.  The  anti-obsessional  effects  of  potent  SRIs  produce  progressive
desensitization of the presynaptic autoreceptors present on 5HT neurons and their nerve
terminals,  thereby increasing synaptic  5HT release in the orbitofrontal  cortex.  Clomipra‐
mine was the first to show beneficial effects on OCD symptoms. The newer generation of
antidepressant  drugs  viz.  fluvoxamine,  fluoxetine,  paroxetine,  sertraline  and  citalopram
have also been found useful in management of OCD. The mean daily dosage is 50–200 mg
for  sertraline,  20–80  mg  for  fluoxetine,  40–60  mg  for  paroxetine  and  150–300  mg  for
Figure 2. High energy use in the brain of a typical person with OCD
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fluvoxamine. The atypical antipsychotics such as risperidone act as new therapeutic options
for  refractory  OCD.  Marble  burying  behavior  of  mice  has  been  used  to  model  anxiety
disorder including obsessive–compulsive disorder (OCD) due to the excessive nature of the
behavior and due to the pharmacological effects of clinical standards. Gaikwad et al., 2007
suggested that LHRH agonist such as leuprolide may be clinically effective in OCD, resulted
dose  dependently  attenuated marble-burying  behavior  in  mice  has  been  used to  model
anxiety disorders viz. obsessive–compulsive disorder. Acute administration of the neuroste‐
roid allopregnanolone (i.c.v.) or its precursor, progesterone, decreased marble burying in
male  mice,  but  administration  of  the  5-reductase  inhibitor  finasteride,  an  allopregnano‐
lone indirect antagonist, did not affect marble burying (Umathe et al., 2009). In addition,
acute  administration  of  the  5-HT2a/2c  antagonist  ritanserin  abolished  the  leuprolide-
induced decrease in marble-burying of male mice without having any effect on locomo‐
tion. Ritanserin treatment on its own had no effect on marble-burying or on locomotion
(Gaikwad et al., 2010). These results suggest that the anti-compulsive effects of GnRH may
depend upon serotonergic  activity,  and specifically,  that  the  effects  of  leuprolide  in  the
marble-burying model are mediated through 5-HT2A/2C receptors (Gaikwad et al., 2010).
9.2. Neurosurgical treatments
Neurosurgical treatments have been used for the management of chronic, severely distressing
forms of OCD where conventional treatments are ineffective. In the United States and Canada,
anterior cingulotomy was the most widely used neurosurgical procedure applied in the
treatment of anxiety refractory OCD. Two surgical techniques have been used: radiofrequency
thermolesion or thermocapsulotomy and the newer radiosurgical or gamma knife capsuloto‐
my techniques. It has been shown that 50–70% of patients with OCD respond favorably to this
type of operation at the end of the follow-up period ranging from 1 to 9 years. The Bilateral
thermolesions are produced by radiofrequency in the anterior cingulate cortex (ACC) (Broad‐
man areas 24 and 32). It has found that 25% of patients with OCD were slightly improved,
31.3% were markedly improved, 12.5% were functionally normal on medication or psycho‐
therapy maintenance and 12.5% were essentially well without any treatment at the mean
follow-up of 9 years. The Y-BOCS used for assessment of OCD symptom severity, resulted a
moderate-to-marked improvement (defined as a 50% or greater reduction in Y-BOCS scores)
in 57% of cases at the mean 13-year follow-up. Approximately 50–70% of patients with OCD
showed good outcome by surgery, indicated no or mild residual symptoms at the follow-up
ranging from 16 months to 8 years. The recent report suggested that good outcome was
observed in only 33% of cases within 1 year of surgery. In the United Kingdom limbic
leucotomy was developed, a technique based on making bilateral lesions of the cingulotomy,
in addition to those of the original subcaudate tractotomy.
9.3. Psychological treatments
Psychological treatments based on cognition-behavioral therapy (CBT) are effective in the
treatment of OCD, alone or in combination with SRIs. The current procedures are in vivo
(real-life) exposure with self-imposed response prevention (EX/RP) which showed benefi‐
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cial effects of this behavioral approach in two patients with severely disabling OCD. The
reduction in OCD symptom severity was found after 3–7 weeks of EX/RP treatment while
no change occurred during the control condition. The goal of CBT treatment is to learn to
respond appropriately to intrusive thoughts and urges of  OCD in new and much more
adaptive ways and to reattribute the belief about “false brain messages” as intimately due
to  a  biomedical  disease  state.  The  therapeutic  effects  showed the  functional  changes  in
interactions between the limbic cortex (including the orbital cortex and anterior cingulate
gyrus) and the basal ganglia that are extremely important in redirecting information flow
toward  the  integration  of  new  behaviorally  significant  environmental  events  during
learning.  This  function  may  be  central  in  the  acquisition  of  more  adapted  patterns  of
behavioral responses during the course of CBT.
10. Conclusion
OCD is an anxiety disorder featuring intrusive and troubling thoughts, which are perceived
as the products of one’s own mind unlike schizophrenia. The Patient affected by OCD feels
compelled to carry out certain stereotyped behaviors, although he recognizes that his behavior
is at times irrational. Entire brain functioning is disturbed in patients suffering from OCD,
thereby producing devastating effects at the work-place as well as at homes of the patients.
OCD is a complicated disorder. Selective serotonin reuptake inhibitors (SSRIs) and to some
extent tricyclic antidepressants form the main stay in the symptomatic treatment of OCD. Most
of the OCD cases are incurable. Therefore, there is a great challenge to discover new drug
treatment for the management of OCD.
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